Small-molecule nociceptin antagonists were synthesized to examine their the
rapeutic potential. After a 4-aminoquinoline derivative was found to bind w
ith the human ORL1 receptor, a series of 4-aminoquinolines and related comp
ounds were synthesized and their binding was evaluated. Elucidation of stru
cture-activity relationships eventually led to the optimum compounds. One o
f the se compounds, N-(4-amino-2-methylquinolin-6-yl) -2-(4-ethylphenoxymet
hyl)benzamide hydrochloride (11) not only antagonized nociceptin-induced al
lodynia in mice but also showed analgesic effect in a hot plate test using
mice and in a formalin test using rats. Its analgesic effect was not antago
nized by the opioid antagonist naloxone. These results indicate that this n
ociceptin antagonist has the potential to become a novel type of analgesic
that differs from mu -opioid agonists.